Cargando…

Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes

Myleodysplastic syndromes (MDS) are pre-malignant hematopoietic diseases that can progress to acute myeloid leukemia (AML) progression in conjunction with changes in immune function. In this model of leukemia evolution, the expansion of immunosuppressive regulatory T cells (Tregs) contributes to imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mailloux, Adam W., Epling-Burnette, Pearlie K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601152/ https://www.ncbi.nlm.nih.gov/pubmed/23524348 http://dx.doi.org/10.4161/onci.22654

Ejemplares similares

Immune dysregulation in myelodysplastic syndrome
por: Sugimori, Chiharu, et al.
Publicado: (2010)

The ART of tumor immune escape
por: Wennerberg, Erik, et al.
Publicado: (2022)

The dual targeting of immunosuppressive cells and oxidants promotes effector and memory T-cell functions against lung cancer
por: Sawant, Anandi, et al.
Publicado: (2014)

Two different “tales” of ATG7: Clinical relevance to myelodysplastic syndromes
por: Ali, Abdullah M., et al.
Publicado: (2016)

Egfl7 promotes tumor escape from immunity
por: Pinte, Sébastien, et al.
Publicado: (2012)

Innate predisposition to immune escape in follicular lymphoma cells
por: Gravelle, Pauline, et al.
Publicado: (2012)

Antigen shedding into the circulation contributes to tumor immune escape
por: Höchst, Bastian, et al.
Publicado: (2012)

Escape from senescence: revisiting cancer therapeutic strategies
por: Zampetidis, Christos P., et al.
Publicado: (2022)

Improving the outcome of adoptive cell transfer by targeting tumor escape
por: Kaluza, Karen M., et al.
Publicado: (2013)

hTERT deficiency in naïve T cells affects lymphocyte homeostasis in myelodysplastic syndrome patients
por: Yang, Lili, et al.
Publicado: (2013)

How the devil facial tumor disease escapes host immune responses
por: Siddle, Hannah V, et al.
Publicado: (2013)

The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8(+) T cells into innate-like effector cells with antitumor activity
por: Wong, Hing C, et al.
Publicado: (2013)

CD56 marks human dendritic cell subsets with cytotoxic potential
por: Roothans, Dessie, et al.
Publicado: (2013)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Alternative end joining, clonal evolution, and escape from a telomere-driven crisis
por: Hendrickson, Eric A, et al.
Publicado: (2015)

Ectopic CD137 expression facilitates the escape of Hodgkin and Reed-Sternberg cells from immunosurveillance
por: Pang, Wan Lu, et al.
Publicado: (2013)

The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
por: Bellone, Matteo, et al.
Publicado: (2013)

IgG4 antibodies and cancer-associated inflammation: Insights into a novel mechanism of immune escape
por: Karagiannis, Panagiotis, et al.
Publicado: (2013)

Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells
por: Végran, Frédérique, et al.
Publicado: (2013)

Empowering scFv with effector cell functions for improved anticancer therapeutics
por: Zhang, Hongtao
Publicado: (2013)

On your marks, get SET(D1A): the race to protect stalled replication forks
por: Begum, Shabana, et al.
Publicado: (2018)

Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity
por: Garg, Abhishek D, et al.
Publicado: (2013)

Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy
por: Fisher, Jonathan, et al.
Publicado: (2014)

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells
por: Kiessling, Rolf, et al.
Publicado: (2012)

Radiation and anti-PD-L1 antibody combinatorial therapy induces T cell-mediated depletion of myeloid-derived suppressor cells and tumor regression
por: Deng, Liufu, et al.
Publicado: (2014)

Radiation-induced tumor dormancy reflects an equilibrium between the proliferation and T lymphocyte-mediated death of malignant cells
por: Liang, Hua, et al.
Publicado: (2013)

High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?
por: Lugade, Amit A, et al.
Publicado: (2013)

The hedgehog’s trick for escaping immunosurveillance: The molecular mechanisms driving myeloid-derived suppressor cell recruitment in hedgehog signaling-dependent tumors
por: Xie, Jingwu
Publicado: (2014)

Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
por: van Luijn, Marvin M., et al.
Publicado: (2012)

Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma
por: Noessner, Elfriede, et al.
Publicado: (2012)

NK cells from malignant pleural effusions are potent antitumor effectors: A clue for adoptive immunotherapy?
por: Vacca, Paola, et al.
Publicado: (2013)

The two faces of regulatory T cells in cancer
por: Blatner, Nichole R, et al.
Publicado: (2013)

Hunting for clues: Regulatory T cells and colorectal cancer
por: Gallimore, Awen, et al.
Publicado: (2012)

Toward understanding the genetics of regulatory T cells in ovarian cancer
por: DeRycke, Melissa S, et al.
Publicado: (2013)

Targeting the right regulatory T-cell population for tumor immunotherapy
por: Weiss, Vivian L., et al.
Publicado: (2012)

Role of Polyamines in Immune Cell Functions
por: Hesterberg, Rebecca S., et al.
Publicado: (2018)

A new strategy to target regulatory T cells in solid tumors
por: Thomas-Schoemann, Audrey, et al.
Publicado: (2013)

Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma
por: Hansen, Wiebke
Publicado: (2013)

Continuous 4–1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapy
por: Chacon, Jessica Ann, et al.
Publicado: (2013)

‘Hardcore’ OX40(+) immunosuppressive regulatory T cells in hepatic cirrhosis and cancer
por: Piconese, Silvia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8dacjj0il1mg17unijtr3nkulf